✉ info@chemsp.cn☎ +86-18553102138 ☎ 0531-84992235
📞 WhatsAppEnglish
591daili 济南圣和化工
首页 › 产品目录 › 匹伐他汀

匹伐他汀

CAS 147511-69-1C25H24FNO4MW 421.5

匹伐他汀(CAS 147511-69-1):分子式 C25H24FNO4、分子量 421.5;类别 有机化学品。

产品描述

匹伐他汀(CAS 147511-69-1)是一种有机化学品原料。其分子式 C25H24FNO4 由 25 个碳、24 个氢、1 个氟、1 个氮、4 个氧 组成。 分子量约为 421.5。公开物性数据显示其LogP 约 3.5。作为化工品采购代理与分销渠道,我们可在国内及跨境渠道为匹伐他汀寻源比价,并安排小批量试样与批次采购;下单前提供完整 COA、质检报告与合规文件,验收以批次 COA 为准。

规格参数

CAS号147511-69-1
分子式C25H24FNO4
分子量421.5
LogP3.5
应用领域MEDICATION、Hydroxymethylglutaryl-CoA Reductase Inhibitors、Methods of Manufacturing: Preparation: Y. Fujikawa et al、European Patent Office patent 304063、eidem、United States of America patent 5011930 (1989
类别有机化学品

用途与场景

登记用途:MEDICATION、Hydroxymethylglutaryl-CoA Reductase Inhibitors、Methods of Manufacturing: Preparation: Y. Fujikawa et al、European Patent Office patent 304063、eidem、United States of America patent 5011930 (1989。

采购档案

这个产品是什么

匹伐他汀 是一种以碳骨架为基础的有机化合物,登记 CAS 号为 147511-69-1,分子式 C25H24FNO4(分子量 421.5),归属于有机化学品大类化工原料。

识别信息

登记 CAS 号:147511-69-1

其分子式 C25H24FNO4 由 25 个碳、24 个氢、1 个氟、1 个氮、4 个氧 组成。

别名/同义词:匹伐他汀 · Pitavastatin

所属分类:有机化学品

常见问题

匹伐他汀 的 CAS 号是多少?

匹伐他汀 的 CAS 登记号为 147511-69-1。

匹伐他汀 的分子式与分子量是多少?

分子式 C25H24FNO4,分子量 421.5。

匹伐他汀 还有哪些别名?

别名/同义词:匹伐他汀、Pitavastatin。

匹伐他汀 的登记用途是什么?

登记用途:MEDICATION、Hydroxymethylglutaryl-CoA Reductase Inhibitors、Methods of Manufacturing: Preparation: Y. Fujikawa et al、European Patent Office patent 304063、eidem、United States of America patent 5011930 (1989。

匹伐他汀 属于哪个分类?

所属分类:有机化学品。

如何在 591daili.cn 采购 匹伐他汀?

请在联系页面提交产品名称、CAS 号与数量,我们作为采购代理在国内及跨境渠道为您寻源比价,安排试样与批次采购,下单前提供 COA 与合规文件。

包装与单证

包装按订单确认,从实验室小包装到吨袋大货,随订单安排而非在页面上写死。每批随货附 COA 分析证书,可另提供 MSDS;若终端用途带有法规限度(食品接触、药品或化妆品),请在询价时说明执行标准,等级按该标准确定。

PubChem 公开数据

匹伐他汀(CAS 147511-69-1)的公开数据库记录,列此仅供独立核对。

危险化学品分类与危害说明

Reported hazard statementsH361 (100%), H362 (100%)

H361 (100%): Suspected of damaging fertility or the unborn child [Warning Reproductive toxicity]

H362 (100%): May cause harm to breast-fed children [Reproductive toxicity, effects on or via lactation]

物理形态与操作说明

  • Very slightly soluble
  • 202.3 Ų [M+H]+ [CCS Type: DT; Buffer gas: N2; Ionization: APCI+; Dataset: TOXCAST; Source Identifier: DTXSID4046448]
  • 203.2 Ų [M+H]+ [CCS Type: DT; Buffer gas: N2; Ionization: ESI+; Dataset: TOXCAST; Source Identifier: DTXSID4046448]
  • 207.8 Ų [M-H]- [CCS Type: DT; Buffer gas: N2; Ionization: ESI-; Dataset: TOXCAST; Source Identifier: DTXSID4046448]
  • 196.7 Ų [M+Na]+ [CCS Type: DT; Buffer gas: N2; Ionization: ESI+; Dataset: TOXCAST; Source Identifier: DTXSID4046448]
  • MW: 493.45. MP: 138-139 °C. Specific optical rotation: +8.84 deg at 32 °C/D (c = 0.92 in chloroform). Soluble in acetonitrile /Pitavastatin lactone/

这个物质在各数据库里的编号

CAS Registry Number147511-69-1
PubChem CID5282452
分子式C25H24FNO4
IUPAC 名称(E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid
UNII(FDA)M5681Q5F9P

数据库记载的用途

  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Preparation: Y. Fujikawa et al., European Patent Office patent 304063; eidem, United States of America patent 5011930 (1989, 1991 both to Nissan Chem. Ind.)
  • Pitavastatin is a relatively newly developed cholesterol lowering agent (statin) that is associated with mild, asymptomatic and self-limited serum aminotransferase elevations during therapy, but has had limited use and has yet to be linked with clinically apparent acute liver injury.
  • Breast Feeding; Lactation; Milk, Human; Anticholesteremic Agents; Hypolipidemic Agents; Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Livalo is indicated as an adjunctive therapy to diet to reduce elevated total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), apolipoprotein B (Apo B), triglycerides (TG), and to increase HDL-C in adult patients with primary hyperlipidemia or mixed dyslipidemia. /Included in US product label/
  • The American College of Cardiology (ACC)/American Heart Association (AHA) cholesterol management guideline recommends statins as first-line therapy for prevention of atherosclerotic cardiovascular disease (ASCVD) in adults. Pitavastatin may be used for primary or secondary prevention in adults when moderate-intensity statin therapy is indicated. /NOT included in US product label/

它在各数据库里的别名

Pitavastatin; 147511-69-1; Itavastatin; pitavastatine; NK 104; pitavastatinum; Pitavastatina; (3R,5S,6E)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid; NK-104; NIKITA; 6-Heptenoic acid, 7-[2-cyclopropyl-4-(4-fluorophenyl)-3-quinolinyl]-3,5-dihydroxy-, (3R,5S,6E)-; M5681Q5F9P; (3R,5S,6E)-7-(2-Cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl)-3,5-dihydroxyhept-6-enoic acid; (E,3R,5S)-7-[2-cyclopropyl-4-(4-fluorophenyl)quinolin-3-yl]-3,5-dihydroxyhept-6-enoic acid; NSC-760423; K-924 component Pivastatin

计算机算出的分子描述符

分子量421.5
XLogP33.5
氢键供体数3
氢键受体数6
可旋转键数8
精确质量421.16893641
单同位素质量421.16893641
拓扑极性表面积90.7
重原子数31
形式电荷0

数据库摘要

Pitavastatin · CAS 147511-69-1 · C25H24FNO4. UNII M5681Q5F9P.

数据来源:PubChem / Wikidata;与随货 COA 不一致时以 COA 为准。

同类推荐

获取 匹伐他汀 报价

供应商:济南圣和化工有限公司 · 一个工作日内回复。

邮件询价 WhatsApp

English page: Pitavastatin

Shenghe Chemical|ChemSP
鲁ICP备19037000号-1